AnaptysBio, Inc. (ANAB)
47.54
-0.19
(-0.40%)
USD |
NASDAQ |
Nov 04, 16:00
47.54
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Market Cap : 1.413B for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 1.419B |
| November 02, 2026 | 1.395B |
| October 30, 2026 | 1.435B |
| October 29, 2026 | 1.446B |
| October 28, 2026 | 1.501B |
| October 27, 2026 | 1.475B |
| October 26, 2026 | 1.450B |
| October 23, 2026 | 1.449B |
| October 22, 2026 | 1.430B |
| October 21, 2026 | 1.425B |
| October 20, 2026 | 1.351B |
| October 19, 2026 | 1.464B |
| October 16, 2026 | 1.386B |
| October 15, 2026 | 1.448B |
| October 14, 2026 | 1.387B |
| October 13, 2026 | 1.355B |
| October 12, 2026 | 1.369B |
| October 09, 2026 | 1.366B |
| October 08, 2026 | 1.374B |
| October 07, 2026 | 1.357B |
| October 06, 2026 | 1.424B |
| October 05, 2026 | 1.463B |
| October 02, 2026 | 1.443B |
| October 01, 2026 | 1.446B |
| September 30, 2026 | 1.494B |
| Date | Value |
|---|---|
| September 29, 2026 | 1.497B |
| September 28, 2026 | 1.510B |
| September 25, 2026 | 1.516B |
| September 24, 2026 | 1.537B |
| September 23, 2026 | 1.509B |
| September 22, 2026 | 1.603B |
| September 21, 2026 | 1.633B |
| September 18, 2026 | 1.641B |
| September 17, 2026 | 1.637B |
| September 16, 2026 | 1.577B |
| September 15, 2026 | 1.587B |
| September 14, 2026 | 1.571B |
| September 11, 2026 | 1.564B |
| September 10, 2026 | 1.601B |
| September 09, 2026 | 1.617B |
| September 08, 2026 | 1.643B |
| September 04, 2026 | 1.649B |
| September 03, 2026 | 1.668B |
| September 02, 2026 | 1.621B |
| September 01, 2026 | 1.605B |
| August 31, 2026 | 1.656B |
| August 28, 2026 | 1.634B |
| August 27, 2026 | 1.663B |
| August 26, 2026 | 1.684B |
| August 25, 2026 | 1.695B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 297.67M |
| Amgen, Inc. | 258.59B |
| Anika Therapeutics, Inc. | 272.61M |
| BioCryst Pharmaceuticals, Inc. | 2.108B |
| Imunon, Inc. | 4.272M |
Market Cap Related Metrics
| PE Ratio | 7.375 |
| PS Ratio | 5.941 |
| Price to Book Value | 133.52 |
| Price to Free Cash Flow | 78.13 |
| Price | 47.54 |
| Earnings Yield | 13.56% |
| Operating PE Ratio | 10.54 |
| Normalized PE Ratio | 7.375 |